Medicine, Nursing and Health Sciences Contact us ASPREE ... · School of Public Health and Preventive Medicine ... the onset of dementia and certain cancers, ... and benefits of aspirin

www.monash.edu

ASPREE

Medicine, Nursing and Health Sciences

School of Public Health and Preventive Medicine

The information in this brochure was correct at the time of publication – August 2011. Monash University reserves the right to alter this information should the need arise.

You should always check with the institution when considering a course. CRICOS provider: Monash University 00008C. MMS326158

Contact usTo contact ASPREE: Tel: 1800 728 745 Email: [email protected]

To contact School of Preventive Health and Preventive Medicine:

Dr Jay Illesinghe Research Administrative Manager

Tel: + 61 03 9903 0929 Fax: + 61 03 9903 0556 Email: Jayamini.Illesinghe@ monash.edu

FundingNIH $50 million US

NHMRC $3.5 million

CSIRO $3.4 million

Victorian Cancer Agency $2 million

Bayer HealthCare is providing the study medication

Primary Ethics ApprovalsRoyal Australian College of General Practitioners

Monash University

www.aspree.org

facebook.com/Monash.University

twitter.com/Monash_FMNHS

Benefits to the Health of AustraliansContribution to medical knowledge about prevention

Increasing capacity to attract similar clinical trials

Training new clinical and public health researchers

Adding value to biomedical research (Biobank)

Improved understanding of health and ageing

Bringing clinical research to regional centres

ASPREE

ASPREE (ASPirin in Reducing Events in the Elderly) will determine if daily low-dose aspirin can delay or prevent a heart attack or stroke, the onset of dementia and certain cancers, such as bowel cancer. It will, for the first time, analyse the risks and benefits of aspirin therapy in healthy older people.

The Trial � Double blind randomised

� 19,000 participants, 12,500 in Australia 6,500 in the USA

� Aged 70 plus, healthy

� Five years follow up

� Half receive aspirin, half placebo

� Collaboration with Australian general practitioners

� ASPREE is the largest primary prevention trial ever undertaken in Australia

Collaborators � Monash University (Australian lead)

� Berman Center, Minnesota (USA lead)

� CSIRO

� University of Melbourne

� University of Tasmania

� Australian National University

Add-on StudiesASPREE Biobank: blood samples on commencement

Purpose: better prediction,earlier treatment of serious disease

ASPREE-ALSOP: questionnaires completed during study

Purpose: improved understanding of the problems of ageing including: mobility, hearing, eyesight, dental care, diet, exercise

Benefits to the Health of AustraliansContribution to medical knowledge about prevention

Increasing capacity to attract similar clinical trials

Training new clinical and public health researchers

Adding value to biomedical research (Biobank)

Improved understanding of health and ageing

Bringing clinical research to regional centres

ASPREE

ASPREE (ASPirin in Reducing Events in the Elderly) will determine if daily low-dose aspirin can delay or prevent a heart attack or stroke, the onset of dementia and certain cancers, such as bowel cancer. It will, for the first time, analyse the risks and benefits of aspirin therapy in healthy older people.

The Trial � Double blind randomised

� 19,000 participants, 12,500 in Australia 6,500 in the USA

� Aged 70 plus, healthy

� Five years follow up

� Half receive aspirin, half placebo

� Collaboration with Australian general practitioners

� ASPREE is the largest primary prevention trial ever undertaken in Australia

Collaborators � Monash University (Australian lead)

� Berman Center, Minnesota (USA lead)

� CSIRO

� University of Melbourne

� University of Tasmania

� Australian National University

Add-on StudiesASPREE Biobank: blood samples on commencement

Purpose: better prediction,earlier treatment of serious disease

ASPREE-ALSOP: questionnaires completed during study

Purpose: improved understanding of the problems of ageing including: mobility, hearing, eyesight, dental care, diet, exercise

www.monash.edu

ASPREE

Medicine, Nursing and Health Sciences

School of Public Health and Preventive Medicine

The information in this brochure was correct at the time of publication – August 2011. Monash University reserves the right to alter this information should the need arise.

You should always check with the institution when considering a course. CRICOS provider: Monash University 00008C. MMS326158

Contact usTo contact ASPREE: Tel: 1800 728 745 Email: [email protected]

To contact School of Preventive Health and Preventive Medicine:

Dr Jay Illesinghe Research Administrative Manager

Tel: + 61 03 9903 0929 Fax: + 61 03 9903 0556 Email: Jayamini.Illesinghe@ monash.edu

FundingNIH $50 million US

NHMRC $3.5 million

CSIRO $3.4 million

Victorian Cancer Agency $2 million

Bayer HealthCare is providing the study medication

Primary Ethics ApprovalsRoyal Australian College of General Practitioners

Monash University

www.aspree.org

facebook.com/Monash.University

twitter.com/Monash_FMNHS